Headlines

CD Genomics has recently launched the Nanopore direct RNA sequencing service for identifying new genes, transcripts, and alternative splicing events, as well as resolving structural variants and repetitive regions The RNA Solutions platform offers services to revolutionize RNA study, targeting ...

Multiomics enables analysis of multiple levels of biological regulation in one sample to link the causes and consequences of complex phenotypes, while also minimizing missed information...

Ultima Genomics emerged from stealth mode with a new high-throughput, low-cost sequencing platform that delivers the $100 genome. Ultima's goal is to unleash a new era in genomics-driven research...

ISF’s science word/phrase of the year is a hunt to bring to limelight a word or phrase which has caught or ought to catch the imagination of the scientific...

  One of the youngest members of the RNA Institute’s 2020 Summer Bioinformatics program, Cristina DeMeo, has put the skills she learned to great use. Cristina, a local high school student has used her knowledge of the computational analysis of large ...

The SARS-CoV-2 NGS Assay has the ability to analyze the entire RNA viral sequence, to determine the presence or absence of the virus. Furthermore, in an optional research-use only (RUO) report the...

The U.S. Food and Drug Administration has granted emergency use authorization for scientists at UCLA Health to begin using a new method of COVID-19 detection using sequencing technology called SwabSeq. The method is capable of testing thousands of...

Anindita “Oni” Basu, PhD, an assistant professor of genetic medicine at the University of Chicago, has received the prestigious National Institutes of Health (NIH) Director’s New Innovator Award. These...

Population genomics company Helix said Monday that it has received Emergency Use Authorization from the U.S. Food and Drug Administration for a COVID-19 test that’s based on next-generation sequencing. It is the first clinical lab to receive approval...

A new study has been initiated to evaluate whole-genome and RNA-sequencing as a first line diagnostic approach for patients in Sweden with acute leukemia. The study will assess the potential of these sequencing approaches to replace...